Mucosal immunity to the pathogens and tumors involving system "lectins of probiotics - glycopolymers"

The overview of own works is devoted to the new insights to mucosal innate immunity functioning. We described multifunctional lectin systems of probiotic bacteria (LSPB) and their complexes which recognize a wide spectrum of selected glycoconjugates. LSPB (separately or in combinations with other antimicrobials and antipathogen factors) are important contributors to biotope distant protection against pathogens. Being metabolomebiotics, LSPB form reversible complexes to natural and artificial glycopolymers of mucin type that allows building on duty dynamic network of directed cascades of replies of mucosal innate immunity. Probiotic molecular-cellular network "LSPB - glycopolymers" serves as an important synergistic system participating in biotope microbiocenosis antipathogen resistance and in Cross-Talking communications with human protective cells and systems to support prolonged healthy status of mucosa. This network influences mucosa pores, affine texture, tropism and redistribution in biotope. Mucosal innate immunity strategies of LSPB and their complexes against microbial and viral pathogens, early tumor-like mucosal cells are proposed. Biological properties of artificial glycopolymers interacted in LS were compared.

mucosa, congenital immunity, probiotic lectins, lectin system, artificial glycolymers, mucins, microbiocenosis, biotope, pathogens, tumor-like cells

1. Lakhtin M.V. Varianty izotipirovaniya komponenta S4 komplementa cheloveka: avtoref. dis. ... kand. biol. nauk. - M., 2008. - 22 s

2. Lakhtin V.M., Afanas'ev S.S., Aleshkin V.A., Nesvizhskii Yu.V., Pospelova V.V., Lakhtin M.V., Voropaeva E.A., Cherepanova Yu.V., Agapova Yu.V. Strategicheskie aspekty konstruirovaniya probiotikov budushchego // Vestnik RAMN. - 2008. - № 2. - S. 33-44

3. akhtin M.V., Afanas'ev S.S., Lakhtin V.M., Aleshkin V.A., Karaulov A.V., Aleshkin A.V., Nesvizhskii Yu.V., Bairakova A.L., Afanas'ev M.S., Voropaeva E.A. Vliyanie lektinov probioticheskikh bakterii na uslovno-patogennyi i probioticheskii kompartmenty mikrobiotsenoza biotopa cheloveka // Astrakhanskii meditsinskii zhurnal. - 2014. - T. 9, № 2. - S. 51-58

4. Lakhtin V.M., Afanas'ev S.S., Lakhtin M.V., Aleshkin V.A., Nesvizhskii Yu.V., Pospelova V.V. Nanotekhnologii i perspektivy ikh ispol'zovaniya v meditsine i biotekhnologii // Vestnik RAMN. - 2008. -№ 4. - C. 50-55

5. Lakhtin V.M., Afanas'ev S.S., Lakhtin M.V., Bairakova A.L., Aleshkin V.A. Diagnostika destabiliziruyushchikh uporyadochennost' biotopa uslovno patogennykh shtammov patsienta v prisutstvii probiotikopodobnogo pula bakterii iz togo zhe populyatsionnogo biotopa // Infektsionnye bolezni. - 2014. - T. 12; Pril. № 1. - S. 171-172

6. Lakhtin M.V., Karaulov A.V., Lakhtin V.M., Aleshkin V.A., Afanas'ev S.S., Nesvizhskii Yu.V., Afanas'ev M.S., Voropaeva E.A., Aleshkin A.V. Lektin glikokon"yugatnye sistemy v organizme cheloveka // Immunopatologiya, allergologiya, infektologiya. - 2012. - № 1. - S. 27-36

7. Lakhtin M.V., Kozlov L.V., Lakhtin V.M., D'yakov V.L. Vyyavlenie defitsitov izotipov C4A i C4B komponentov komplementa cheloveka izoelektrofokusirovaniem i po razlichiyu v khimicheskoi reaktsionnoi sposobnosti aktivirovannykh form // Bioorganicheskaya khimiya. - 2007. - T. 33. - S. 464-469

8. Lakhtin M.V., Lakhtin V.M., Aleshkin V.A., Afanas'ev S.S., Aleshkin A.V. Lektiny i fermenty v biologii i meditsine. - M.: Dinastiya, 2010. - 496 s

9. Lakhtin M.V., Lakhtin V.M., Afanas'ev S.S., Aleshkin V.A., Korsun V.F., Afanas'ev M.S. Lektiny: v rastvorakh i sorbirovannye, aktivnye i latentnye, sistemnye i setevye, flyuorestsentnye i khemilyu-minestsentnye, v regulyatsii sborok i degradatsii, sinergisticheskie i sinbioticheskie // Zdorov'e i obrazovanie v XXI veke. - 2014. - T. 16, № 3. - S. 64-68

10. Lakhtin M.V., Lakhtin V.M., Cherepanova Yu.V., Pospelova V.V., Afanas'ev S.S., Aleshkin V.A. Ranzhirovanie kachestv proizvodstvennykh ingredientnykh probioticheskikh shtammov bifidobakterii i laktobatsill cheloveka dlya prognozirovaniya novykh probioticheskikh formul // Sb. materialov mezhdunar. nauch.-tekhn. konf. «Sovremennye dostizheniya biotekhnologii» i mezhdunarodnogo nauchno-prakticheskogo seminara «Fenomen molochnoi syvorotki: sintez nauki, teorii i praktiki» (g. Stavropol', 21-23 iyunya, 2011). - M.: NOU «Obrazovatel'nyi nauchnotekhnicheskii tsentr molochnoi promyshlennosti», 2011. - Ch. 2. - S. 49-51

11. Bergstrom KSB, Xia L (2013). Mucin-type O-glycans and their roles in intestinal homeostasis. Glycobiol-ogy, 23 (9), 1026-1037

12. Crouzier T, Jang H, Ahn J, Stocker R, Ribbeck K (2013). Cell patterning with mucin biopolymers. Biomacromolecules, 14 (9), 3010-3016

13. Domino SE, Hurd EA, Thomsson KA, Karnak DM, Larsson JMH, Thomsson E, Bäckström M, Hansson GC (2009). Cervical mucins carry a(1,2) fucosylated glycans that partly protect from experimental vaginal candidiasis. Glycoconjugate J., 26 (9), 1125-1134

14. Jakobsson HE, Rodri'guez-Pineiro AM, Schütte A, Ermund A, Boysen P, Bemark M, Sommer F, Bäckhed F, Hansson GC, Johansson MEV (2015). The composition of the gut microbiota shapes the colon mucus barrier. EMBO Reports, 16 (2), 164-177

15. Kavanaugh NL, Zhang AQ, Nobile CJ, Johnson AD, Ribbeck K (2014). Mucins suppress virulence traits of Candida albicans. mBio, 5 (6), e01911-14

16. Lakhtin M, Aleshkin V, Lakhtin V, Afanasiev S, Pozhalostina L, Pospelova V (2010). Probiotic lactobacillus and bifidobacterial lectins against Candida albicans and Staphylococcus aureus clinical strains: New class of pathogen biofilm destructors. Probiotics and Antimicrobial Proteins, 2, 186-196

17. Lakhtin V, Lakhtin M, Aleshkin V (2011). Lectins of living organisms. Anaerobe, 17, 452-455

18. Lakhtin MV, Lakhtin VM, Aleshkin VA (2011). Lectin and enzyme relationships in microbiology. International Journal of Molecular and Clinical Microbiology, 1, 9-14

19. Lakhtin M, Lakhtin V, Aleshkin V, Afanasiev S (2011). Lectins of beneficial microbes: system organization, functioning and functional superfamily. Beneficial Microbes, 2, 155-165

20. Lakhtin MV, Lakhtin VM, Aleshkin AV, Afanasiev SS, Aleshkin VA (2013). Differences and similarities between new probiotic bifidobacterial and lactobacillus lectin systems interacting to glycoconjugates. Glycoconjugate J., 30, 375-376

21. Lakhtin MV, Lakhtin VM, Aleshkin AV, Afanasiev SS, Aleshkin VA (2013). Functional similarities and differences between new lectin systems in human organism: protein hormone and probiotic bacterial. Glycoconjugate J., 30, 370

22. Lakhtin M, Lakhtin V, Aleshkin A, Bajrakova A, Afanasiev S, Aleshkin V (2012). Lectin systems imitating probiotics: Potential for biotechnology and medical microbiology. Probiotics, 417-432

23. Lakhtin VM, Lakhtin MV, Bajrakova AL, Afanasiev SS, Aleshkin VA (2013). Candida albicans: new aspects of pathogenicity, interaction to antifungals, biofilms and preventive anti-candida strategies. Candida albicans: Symptoms, causes and treatment options, 145-152

24. Lakhtin MV, Lakhtin VM, Afanasiev SS, Bajrakova AL, Aleshkin VA, Afanasiev MS, Karaulov AV, Korsun VF (2014). Human healthy status supported by probiotic systems recognizing glycoconjugates: one more strategy of supporting healthy biotope. European Science and Technology: materials of the IX international research and practice conference (Munich, December 24-25,2014)

25. Lazaris AC, Chatzigianni EB, Paraskeva-kou H, Tseleni-Balafouta S, Davaris PS (2000). Lectin histochemistry as a predictor of dysplasia grade in colorectal adenomas. Pathol. Oncol. Res., 6 (4), 265-271

26. Mukherjee S, Vaishnava S, Hooper LV (2008). Multilayered regulation of intestinal antimicrobial defense. Cell Mol. Life Sci., 65 (19), 3019-3027

27. Van Tassell ML, Miller MJ (2011). Lactobacillus adhesion to mucus. Nutrients, 3, 613-636

28. Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI et al. (2014). Potential of fecal microbiota for early-stage detection of colorectal cancer. Molecular Systems Biology, 10, 766